Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Sasebo
Clinical trial register · Japan

Clinical Trials in Sasebo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Sasebo

7 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Active, closed
Merck Sharp & Dohme LLC
Phase 2
185
Hanishina-gun, Sasebo, Nagaoka, Tokorozawa, Chūō, Miyazaki
2025-10-08
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Fukuoka, Kita Gun, Nagoya, Osaka, Ōita, Sasebo, Sendai, tabashi City
2025-02-21
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Chūōku, Fuchū, Fukuoka, Kawachi-Nagano, Naha, Okayama, Sapporo, Sasebo
2024-12-04
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Nagoya, Kitakyushu, Sapporo, Yokohama, Kuwana, Sasebo, Kurashiki, Bunkyo Ku
2023-10-27
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Nagoya, Kitakyushu, Sapporo, Yokohama, Kuwana, Sasebo, Kurashiki, Bunkyo Ku
2022-08-04
Active, closed
Regeneron Pharmaceuticals
Phase 1
146
Nagoya, Kurume, Ōta, Kobe, Kanazawa, Sagamihara, Yokohama, Sasebo
2017-06-21
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-japan/city/sasebo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Sasebo.

How many clinical trials are recruiting in Sasebo?

0 of the 7 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Sasebo), 7 studies
PhaseStudiesRecruitingShare
Phase 35071.4%
Phase 11014.3%
Phase 21014.3%

Most active sponsors

Lead sponsors with the most studies (Sasebo)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC20
Novartis Pharmaceuticals20
Bristol-Myers Squibb10
Merck Sharp & Dohme LLC10
Regeneron Pharmaceuticals10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.